Flavokawain A: A Natural MAO‐A Inhibitor With Therapeutic Promise for Depression

Documenti analoghi

• Lazertinib: A Cardio‐Safer Alternative to Osimertinib for Epidermal Growth Factor Receptor L858R/T790M Double‐Mutant Tyrosine Kinase Resistant Non‐Small Cell Lung Cancer
  di: Chandrakant S. Gawli, et al.
  Pubblicazione: (2025)
• Integrated Computational Approach for Designing Potent EGFR‐TK Inhibitors: QSAR, Docking, ADMET, and Molecular Dynamics Studies
  di: Shital M. Patil, et al.
  Pubblicazione: (2025)
• Repurposing Non‐Nucleosidic Reverse Transcriptase Inhibitors (NNRTIs) to Overcome EGFR T790M‐Mediated Acquired Resistance in Non‐Small Cell Lung Cancer
  di: Iqrar Ahmad, et al.
  Pubblicazione: (2024)
• Orthoallosteric EGFR‐TKIs: A New Paradigm in NSCLC Treatment Strategy Targeting the C797S Mutation
  di: Iqrar Ahmad, et al.
  Pubblicazione: (2024)
• A Comprehensive Review of The Molecular Dynamic Study Of Chalcones, Coumarins and Chromones as Selective MAO‐B Inhibitors [2015‐Till Date]
  di: Riya Rachel Thomas, et al.
  Pubblicazione: (2024)